US 8163707
4′-allene-substituted nucleoside derivatives
granted A61PA61P31/12A61P31/18
Quick answer
US patent 8163707 (4′-allene-substituted nucleoside derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P31/12, A61P31/18